Syra Health Corp. Class A Common Stock revenue growth has been varied year-over-year.

What is SYRA's revenue growth rate?

Historical revenue data is available for Syra Health Corp. Class A Common Stock to analyze growth trends.

How fast is SYRA earnings growing?

Earnings growth data is available for Syra Health Corp. Class A Common Stock analysis.

What is SYRA's profit margin?

Profit margin data is available for Syra Health Corp. Class A Common Stock.

SYRA Revenue & Earnings Growth Analysis 2026 - Is Syra Health Corp. Class A Common Stock Growing?

Growth Summary

Syra Health Corp. Class A Common Stock (SYRA) has experienced challenges in growth. The company operates in the Healthcare sector, specifically in the Medical Care Facilities industry.

Over the past 2 years, Syra Health Corp. Class A Common Stock has achieved a revenue compound annual growth rate (CAGR) of 19.2%, while earnings have grown at 33.2% CAGR.

Latest Revenue

$7.98M

Net Income

$-3759238.00

5-Year Revenue CAGR

19.2%

2 years of data

Net Margin

N/A

Latest period

Revenue Growth Over Time

Historical revenue and profitability trends for Syra Health Corp. Class A Common Stock

The chart above illustrates Syra Health Corp. Class A Common Stock's revenue trajectory over the past 2 years. The revenue pattern shows the challenges the company has faced in recent periods.

Year-over-Year Growth Rates

Annual percentage change in revenue and earnings

Growth rates provide insight into the momentum of Syra Health Corp. Class A Common Stock's business.

Profit Margin Trends

How efficiently Syra Health Corp. Class A Common Stock converts revenue into profit

Understanding Profit Margins

Profit margins reveal how much of each dollar of revenue Syra Health Corp. Class A Common Stock retains at different stages:

Gross Margin (N/A%): What remains after direct production costs
Operating Margin (N/A%): Profit from core operations before interest and taxes
Net Margin (N/A%): Final profit after all expenses

Future Growth Outlook

Analyst estimates and forward-looking indicators

Price Target

$1.80

Analyst consensus

What Analysts Are Saying

Wall Street analysts project Syra Health Corp. Class A Common Stock to continue focusing on sustainable operations.

Growth Analysis Conclusion

Based on our comprehensive analysis, Syra Health Corp. Class A Common Stock (SYRA) demonstrates declining growth characteristics.

Key Takeaways:

Revenue Growth:, 19.2% CAGR over 2 years
Profitability: shows the company is investing in growth over short-term profits
Efficiency:

Investment Considerations

This growth analysis provides a comprehensive view of Syra Health Corp. Class A Common Stock's historical performance and future outlook. Investors should consider these growth metrics alongside valuation, competitive positioning, and broader market conditions when making investment decisions. Past performance does not guarantee future results.